Vascular Biogenics Ltd.
NASDAQ:VBLT
0.156 (USD) • At close October 16, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -32.304 | -29.92 | -24.225 | -19.457 | -20.458 | -10.138 | -16.002 | -14.888 | -17.407 | -17.37 | -12.225 |
| Depreciation & Amortization
| 1.058 | 1.256 | 1.194 | 1.714 | 1.156 | 0.156 | 0.13 | 0.122 | 0.135 | 0.169 | 0.197 |
| Deferred Income Tax
| 0 | -0.004 | -0.163 | 0.922 | 0.885 | 0.064 | 0.232 | 0.19 | 0.427 | -0.045 | 0.348 |
| Stock Based Compensation
| 2.555 | 1.968 | 1.661 | 2.251 | 3.867 | 4.152 | 1.42 | 1.041 | 2.617 | 0.494 | 0.465 |
| Change In Working Capital
| -2.609 | 1.703 | -2.076 | 2.62 | -0.244 | 2.276 | 1.071 | 0.432 | -1.802 | 2.013 | -1.541 |
| Accounts Receivables
| 0 | 0.129 | -0.129 | 0 | 2 | -2 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | -0.026 | 0.103 | 0 | -0.019 | 0.79 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -3.523 | 2.371 | -1.37 | 2.136 | -1.691 | 0.421 | 0.472 | 1.355 | -0.653 | 0.039 | 0.081 |
| Other Working Capital
| 0.914 | -0.771 | -0.68 | 0.484 | -0.534 | 3.855 | 0.599 | -0.923 | -1.149 | 1.974 | -1.622 |
| Other Non Cash Items
| -0.294 | 0.013 | 0.231 | -0.747 | -0.886 | -0.267 | -0.031 | 0.09 | 2.754 | 1.565 | 0.096 |
| Operating Cash Flow
| -31.594 | -24.984 | -23.378 | -12.697 | -15.68 | -3.821 | -13.412 | -13.203 | -13.703 | -13.129 | -13.008 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -0.812 | -1.465 | -0.051 | -0.073 | -2.229 | -6.482 | -0.491 | -0.09 | -0.057 | -0.032 | -0.155 |
| Acquisitions Net
| -28.108 | 0 | 0 | 0 | 0 | 14.358 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -3 | -51.109 | -41.085 | -63.527 | -21 | -81.332 | -3.6 | -30 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 31.108 | 37.085 | 51.027 | 57 | 47.958 | 66.974 | 0 | 0 | 1.494 | 6.51 | 6.696 |
| Other Investing Activites
| 28.108 | 0 | 0 | 0 | 0.004 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 27.296 | -15.489 | 9.891 | -6.6 | 24.733 | -20.84 | -4.091 | -30.09 | 1.437 | 6.478 | 6.541 |
| Financing Activities: | |||||||||||
| Debt Repayment
| 0 | -0.104 | -0.391 | -0.759 | -0.088 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0.022 | 34.753 | 17.458 | 0.002 | 13.725 | 19.031 | 21.859 | 13.651 | 34.879 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | 14.46 | 0 | 0 | 0.034 | 0.479 | 0.121 | 0.095 | 5.205 | 0 | 0 |
| Financing Cash Flow
| 0.022 | 49.109 | 17.067 | -0.757 | 13.671 | 19.51 | 21.98 | 13.746 | 40.084 | 10 | 0 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| -0.047 | 0.015 | 0.175 | 0.143 | -0.071 | 0.26 | 0.018 | -0.146 | -0.412 | 0.092 | 0.094 |
| Net Change In Cash
| -4.323 | 8.651 | 3.755 | -19.911 | 22.653 | -4.891 | 4.495 | -29.693 | 27.406 | 3.441 | -6.373 |
| Cash At End Of Period
| 18.025 | 22.348 | 13.697 | 9.436 | 29.347 | 6.694 | 11.585 | 7.09 | 36.783 | 9.377 | 5.936 |